glp-1 news nov 2025 November in review: breakthroughs, UPFs under fire, Novonesis advances healthy longevity GLP-1 RA prescription trends: January

Additionally, the long-term safety profile of Ozempic specifically for weight loss in non-diabetic individuals remains less extensively studied

In many ways, your microbiome acts like a metabolic control panel influencing hunger, satiety, and energy regulation

To continue, please confirm that you are a healthcare professional below

Glucagon-Like Peptide 1 Receptor Agonist Use and Risk of Thyroid Cancer: Scandinavian Cohort Study

Potential for Combination Therapies Medications like tirzepatide combine GLP-1 and GIP agonism for enhanced metabolic benefits

Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program